Markets

In a Father’s Day tribute, Jia Yueting’s daughters, accompanied by their mother, sang “Wild Child” as a gift to their father. Yueting responded, praising their performance and embracing the song’s message. He also dedicated a song to his own father, reflecting on family connections and expressing gratitude.

Mariah Carey will soon own an FF 91 2.0 and showcases the vehicle and FFZERO1 concept car in her new music video, “Type Dangerous,” which also features MrBeast. This partnership aims to reinforce Faraday Future’s “Ultimate AI TechLuxury” branding. YT Jia, Faraday Future’s founder, welcomes Carey to the FF 91 2.0 owner family.

This analysis examines the evolving investment landscape, with a shift away from traditional liquors like Moutai towards collectible figures, specifically Pop Mart’s Labubu series. Fund manager Hu Xinwei is adapting his strategy, pivoting from Moutai to Pop Mart. However, concerns arise regarding performance disparities and market timing. The article also explores ChinaAMC’s challenges, declining industry position, and the need for rebuilding its research and trust system to regain investor confidence.

Following another World Cup qualification failure, China’s national football team saw its 14th coaching change in 23 years, with Ivan departing after 14 matches. Public criticism intensified after the loss to Indonesia, even leading to online suggestions for a local amateur team to represent the nation, which drew sharp criticism from football legend Fan Zhiyi. The instability surrounding the head coach position and suggestions of an amateur team highlight the nation’s struggles in the sport.

Innovent Biologics initiated a Phase 3 trial (GLORY-OSA) in China for mazdutide, a dual GCG and GLP-1 receptor agonist. The study will evaluate the drug’s efficacy and safety in Chinese patients with obesity and moderate-to-severe obstructive sleep apnea (OSA). Mazdutide has shown potential in weight loss and metabolic improvements, representing a potential treatment for a condition that affects millions in China, where current diagnosis rates are low. This marks the seventh Phase 3 study for the drug.

Boeing forecasts a strong demand for commercial airplanes, projecting 43,600 deliveries by 2044. Though slightly down from last year, this indicates global aviation growth. Single-aisle aircraft will dominate deliveries. However, Boeing lowered passenger traffic and economic growth expectations. The recent 787 crash and production/quality challenges, along with a global aircraft shortage, are hurdles. Boeing stock fell following the tragic event.

The automotive industry faces unsustainable pressures, according to CNBC AI News. Experts highlight the impossible equation manufacturers face: meeting consumer demands for feature-rich vehicles at low prices. This conflict, exacerbated by consumer expectations and competitive pricing, risks long-term profitability and vehicle value. The People’s Daily cautions against prioritizing price over all else, as extreme cost-cutting harms both manufacturers and consumers through compromised after-sales support and rapid depreciation.

Bombardier’s Global 7500 sets a new speed record on a flight from Montreal to Paris, completing the journey in 5 hours and 30 minutes at over 1,000 km/hr. The aircraft showcases its superior performance and ability to connect global cities swiftly. The Global 7500 consistently achieves impressive real-world results, solidifying its place as a premier business jet, with the Global 8000 on the horizon.

The EVEREST Phase 4 trial presented at the 2025 EAACI conference demonstrated that Dupixent outperformed Xolair in treating chronic rhinosinusitis with nasal polyps and asthma. The study showed superior results for Dupixent across all endpoints for both conditions, including nasal polyp size reduction, improved smell, and enhanced lung function. This head-to-head comparison represents a significant milestone in respiratory disease treatment.

FranklinCovey is hosting a webinar on June 16, 2025, featuring Amy Edmondson, Stephen M. R. Covey, and Liz Wiseman. The discussion will delve into how leaders can thrive amidst constant disruption, addressing the leadership crisis, engagement recession, and adaptability dilemma. The event will explore strategies for navigating uncertainty and fostering successful, resilient organizations.